APOTHEEK DIERICKX: what changed
APOTHEEK DIERICKX
Largest movements
- Cash -€312,035
down €312,035 (-54.7%), from €570,585 to €258,550
mainly Contributions, distributions and other (-€351,000) and Receivables within one year (-€23,767)
- Stocks and contracts -€24,787
down €24,787 (-13.7%), from €180,464 to €155,677
- Receivables within one year +€23,767
up €23,767 (+19.1%), from €124,272 to €148,039
of which Trade receivables: +€23,056
- Contributions -€351,000
down €351,000 (-95.0%), from €369,592 to €18,592
- Reserves +€28,486
up €28,486 (+8.2%), from €345,678 to €374,164
of which Distributable reserves: +€28,486
- Trade debts +€10,545
up €10,545 (+6.9%), from €152,569 to €163,114
- Gross operating margin -€38,790
down €38,790 (-13.5%), from €287,567 to €248,777
- Staff costs +€14,451
up €14,451 (+8.4%), from €171,259 to €185,710
- Taxes -€13,757
down €13,757 (-56.5%), from €24,332 to €10,575
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €965,048 | €647,194 | -€317,855 | -32.9% |
| Fixed assets | 21/28 | €60,149 | €50,843 | -€9,306 | -15.5% |
| Tangible fixed assets | 22/27 | €60,149 | €50,843 | -€9,306 | -15.5% |
| Land and buildings | 22 | €55,897 | €43,971 | -€11,926 | -21.3% |
| Plant, machinery and equipment | 23 | - | €1,601 | +€1,601 | |
| Furniture and vehicles | 24 | €4,252 | €5,271 | +€1,019 | +24.0% |
| Current assets | 29/58 | €904,899 | €596,351 | -€308,549 | -34.1% |
| Amounts receivable after more than one year | 29 | €1,015 | €1,015 | = | 0.0% |
| Other amounts receivable | 291 | €1,015 | €1,015 | = | 0.0% |
| Stocks and contracts in progress | 3 | €180,464 | €155,677 | -€24,787 | -13.7% |
| Stocks | 30/36 | €180,464 | €155,677 | -€24,787 | -13.7% |
| Amounts receivable within one year | 40/41 | €124,272 | €148,039 | +€23,767 | +19.1% |
| Trade receivables | 40 | €114,711 | €137,767 | +€23,056 | +20.1% |
| Other amounts receivable | 41 | €9,561 | €10,273 | +€711 | +7.4% |
| Current investments | 50/53 | €18,311 | €18,311 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €570,585 | €258,550 | -€312,035 | -54.7% |
| Deferred charges and accrued income | 490/1 | €10,251 | €14,758 | +€4,507 | +44.0% |
| Total equity and liabilities | 10/49 | €965,048 | €647,194 | -€317,855 | -32.9% |
| Equity | 10/15 | €715,270 | €392,756 | -€322,514 | -45.1% |
| Contributions | 10/11 | €369,592 | €18,592 | -€351,000 | -95.0% |
| Reserves | 13 | €345,678 | €374,164 | +€28,486 | +8.2% |
| Tax-exempt reserves | 132 | €462 | €462 | = | 0.0% |
| Distributable reserves | 133 | €345,216 | €373,702 | +€28,486 | +8.3% |
| Amounts payable | 17/49 | €249,778 | €254,438 | +€4,660 | +1.9% |
| Amounts payable within one year | 42/48 | €246,451 | €248,605 | +€2,154 | +0.9% |
| Trade debts | 44 | €152,569 | €163,114 | +€10,545 | +6.9% |
| Suppliers | 440/4 | €152,569 | €163,114 | +€10,545 | +6.9% |
| Taxes, remuneration and social security | 45 | €44,161 | €34,963 | -€9,198 | -20.8% |
| Taxes | 450/3 | €16,115 | €12,473 | -€3,642 | -22.6% |
| Remuneration and social security | 454/9 | €28,046 | €22,490 | -€5,556 | -19.8% |
| Other amounts payable | 47/48 | €49,721 | €50,528 | +€807 | +1.6% |
| Accrued charges and deferred income | 492/3 | €3,327 | €5,833 | +€2,506 | +75.3% |
| Remuneration, social security and pensions | 62 | €171,259 | €185,710 | +€14,451 | +8.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €20,811 | €21,645 | +€833 | +4.0% |
| Other operating charges | 640/8 | €1,541 | €934 | -€607 | -39.4% |
| Gross operating margin | 9900 | €287,567 | €248,777 | -€38,790 | -13.5% |
| Operating profit (loss) | 9901 | €93,956 | €40,489 | -€53,467 | -56.9% |
| Financial income | 75/76B | €1,801 | €3,117 | +€1,316 | +73.1% |
| Recurring financial income | 75 | €1,801 | €3,117 | +€1,316 | +73.1% |
| Financial charges | 65/66B | €4,999 | €4,545 | -€454 | -9.1% |
| Recurring financial charges | 65 | €4,999 | €4,545 | -€454 | -9.1% |
| Profit (loss) for the period before taxes | 9903 | €90,759 | €39,061 | -€51,697 | -57.0% |
| Income taxes | 67/77 | €24,332 | €10,575 | -€13,757 | -56.5% |
| Profit (loss) for the period | 9904 | €66,426 | €28,486 | -€37,940 | -57.1% |
| Profit (loss) for the period to be appropriated | 9905 | €66,426 | €28,486 | -€37,940 | -57.1% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.